Friday, July 10, 2026

Drug profile · INN

a/vietnam/1194/2004

a/vietnam/1194/2004 (AFLUNOV) is an FDA-listed pharmaceutical active ingredient.

EMA: application withdrawn
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — a/vietnam/1194/2004
Class
Route
Patents
0
Programs
3
Data quality
0.83

Quick answer

a/vietnam/1194/2004 (AFLUNOV) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN a/vietnam/1194/2004
Brand AFLUNOV

Approval history

Authority Status Date
EMA application withdrawn

Pipeline programs

  1. APHP200073 Phase 3 · PARItec · Erythema multiforme (EM) in its severe form managed at the h
  2. H5N1 adjuvanted split virus vaccine (A/Vietnam/1194/2004 strain) Phase 3 · GSK Glaxo Smith · Influenza
  3. ETNA Phase 2 · George Institute for · Relapsed/refractory neuroblastoma and other solid tumours

Frequently asked questions

What is a/vietnam/1194/2004?

a/vietnam/1194/2004 (AFLUNOV) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for a/vietnam/1194/2004?

AFLUNOV is a marketed brand name for a/vietnam/1194/2004. Check FDA Drugs@FDA for the current US label holder and prescribing information.